Impact of thyroid dysfunction on serum cystatin C

Slides:

Advertisements

Similar presentations

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Reduced renal function in patients with simple renal cysts

Volume 54, Issue 2, Pages (August 1998)

A trial of thyroxine in acute renal failure

Seeing the sodium in a patient with hypernatremia

Volume 57, Issue 5, Pages (May 2000)

Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.

Volume 80, Issue 6, Pages (September 2011)

Better nephrology for mice—and man

Volume 77, Issue 1, Pages 5-6 (January 2010)

Infection and chronic allograft dysfunction

How to interpret the eGFR in patients with small body surface area

Methotrexate in the urine

Volume 58, Issue 5, Pages (November 2000)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Lipid redistribution in renal dysfunction

Volume 70, Issue 11, Pages (December 2006)

Body weight is a fluctuating parameter in hemodialysis patients

Kamila Czene, Ph.D., Kari Hemminki Kidney International

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 87, Issue 2, Pages (February 2015)

The calcium–phosphorus in guidelines for CKD-MBD

Blood pressure targets in hemodialysis patients

Volume 73, Issue 12, Pages (June 2008)

Capturing the in vivo molecular signature of the podocyte

The third World Kidney Day: Looking back and thinking forward

Effects of hemodialysis on cardiac function

Volume 66, Issue 2, Pages (August 2004)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Alternate-day dialysis may be needed for hemodialysis patients

Volume 61, Issue 4, Pages (April 2002)

Volume 76, Issue 1, Pages (July 2009)

Reduced renal function in patients with simple renal cysts

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Volume 78, Issue 5, Pages (September 2010)

Nephrology Crossword: Glomerulonephritis

Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Homocysteine, renal function, and risk of cardiovascular disease

Volume 73, Issue 9, Pages (May 2008)

Hemoglobin variability in epoetin-treated hemodialysis patients

Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients Jesús Hermida, Rafael Romero, J. Carlos Tutor

Daily nocturnal home hemodialysis

Volume 79, Issue 4, Pages (February 2011)

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Volume 63, Issue 2, Pages (February 2003)

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Volume 70, Issue 3, Pages (August 2006)

A trial of thyroxine in acute renal failure

Volume 71, Issue 9, Pages (May 2007)

Volume 68, Issue 1, Pages (July 2005)

Volume 70, Issue 5, Pages (September 2006)

Volume 75, Issue 7, Pages (April 2009)

Volume 82, Issue 9, Pages (November 2012)

The international realities of live donor kidney transplantation

The International Pediatric Peritonitis Registry: Starting to walk

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis Nauman Siddiqi, Maureen A. McBride,

Volume 57, Issue 2, Pages (October 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases Martina Franz, Wolfgang Woloszczuk,

Presentation transcript:

Impact of thyroid dysfunction on serum cystatin C Manuel Fricker, Peter Wiesli, Michael Brändle, Beat Schwegler, Christoph Schmid Kidney International Volume 63, Issue 5, Pages 1944-1947 (May 2003) DOI: 10.1046/j.1523-1755.2003.00925.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Serum creatinine and cystatin C (CysC) in patients treated for hypothyroidism (A andB) and hyperthyroidism (C andD). Values are shown at diagnosis of hypothyroidism and hyperthyroidism, respectively, and when free thyroxine (fT4) returned into the normal range. Kidney International 2003 63, 1944-1947DOI: (10.1046/j.1523-1755.2003.00925.x) Copyright © 2003 International Society of Nephrology Terms and Conditions